Lenalidomide maintenance treatment after an autologous stem cell transplant for newly diagnosed multiple myeloma

Equality Impact Assessment (Guidance development) (PDF 137 KB)

Final draft guidance

Committee papers (PDF 3.41 MB)

Public committee slides (PDF 1.36 MB)

Final appraisal document (PDF 247 KB)

Draft guidance: 1

Appraisal consultation document (PDF version) (PDF 275 KB)

Appraisal consultation document (online commenting)

Committee papers (PDF 5.48 MB)

Public committee slides (PDF 1.14 MB)

Equality impact assessment (Scoping) (PDF 123 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 257 KB)

Final stakeholder list (PDF 212 KB)

Final scope (PDF 169 KB)

Multiple myeloma - lenalidomide: equality impact assessment (PDF 46 KB)

Multiple myeloma - lenalidomide: comments on the provisional matrix - May 2012 (PDF 42 KB)

Multiple myeloma - lenalidomide: response to consultee and commentator comments on the draft scope - May 2012 (PDF 102 KB)

Multiple myeloma - lenalidomide: final matrix of consultees and commentators - May 2012 (PDF 57 KB)

Multiple myeloma - lenalidomide: final scope - May 2012 (PDF 47 KB)

Multiple myeloma - lenalidomide: draft scope for consultation (pre-referral) - March 2011 (PDF 55 KB)

Multiple myeloma - lenalidomide: provisional matrix (pre-referral) - March 2011 (PDF 57 KB)